Searched query = "Prader-Willi syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
|December 2006||14/11/2006||Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)||Investigation of the Developmental, Nutritional and Hormonal Regulation of Ghrelin in Children and Young Adults With Prader-Willi Syndrome (PWS): Octreotide Intervention Sub-study||Prader-Willi Syndrome||Drug: Octreotide;Drug: Placebo||Duke University||National Institutes of Health (NIH);National Center for Research Resources (NCRR);Novartis||Terminated||5 Years||21 Years||All||5||N/A||United States|
|August 2005||13/4/2011||Ghrelin Suppression by Octreotide in Prader-Willi||Ghrelin Suppression by Sandostatin LAR® Depot (Octreotide Acetate for Injectable Suspension) in Patients With Prader-Willi Syndrome||Prader Willis Syndrome||Drug: Placebo;Drug: Octreotide||Oregon Health and Science University||NULL||Active, not recruiting||18 Years||N/A||Male||2||N/A||NULL|